112137-89-0,MFCD00869984
Catalog No.:AA008RHA

112137-89-0 | (+/-)-15-DEOXY-[16RS]-16-HYDROXY-16-METHYLPROSTAGLANDIN E1

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥97%
in stock  
$80.00   $56.00
- +
5mg
≥97%
in stock  
$356.00   $249.00
- +
10mg
≥97%
in stock  
$670.00   $469.00
- +
50mg
≥97%
in stock  
$2,358.00   $1,650.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008RHA
Chemical Name:
(+/-)-15-DEOXY-[16RS]-16-HYDROXY-16-METHYLPROSTAGLANDIN E1
CAS Number:
112137-89-0
Molecular Formula:
C21H36O5
Molecular Weight:
368.5075
MDL Number:
MFCD00869984
SMILES:
CCCCC(CC=CC1C(O)CC(=O)C1CCCCCCC(=O)O)(O)C
Properties
Computed Properties
 
Complexity:
473  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
1  
Formal Charge:
0  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
13  
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.3  

Downstream Synthesis Route

[1]CurrentPatentAssignee:YOOOOKJOON;LIFEXBIOLABS-US2021/139435,2021,A1Locationinpatent:Paragraph0171-0173

[1]CurrentPatentAssignee:YOOOOKJOON;LIFEXBIOLABS-US2021/139435,2021,A1Locationinpatent:Paragraph0147-0149

Literature

Title: Validated method for the determination of misoprostol acid in whole blood by ultra performance liquid chromatography-tandem mass spectrometry.

Journal: Journal of pharmaceutical and biomedical analysis 20121201

Title: Effect of bacterial vaginosis on the pharmacokinetics of misoprostol in early pregnancy.

Journal: Human reproduction (Oxford, England) 20120201

Title: Development and validation of highly sensitive method for determination of misoprostol free acid in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110915

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Pharmacokinetics of repeated doses of misoprostol.

Journal: Human reproduction (Oxford, England) 20090801

Title: Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.

Journal: Human reproduction (Oxford, England) 20070701

Title: Determination of misoprostol acid in human plasma by liquid chromatography coupled to tandem mass spectrometry.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601

Title: The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration.

Journal: European journal of obstetrics, gynecology, and reproductive biology 20030501

Title: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

Journal: Biochimica et biophysica acta 20000117

Title: Vijaya Bharathi D, et al. Development and validation of highly sensitive method for determination of misoprostol free acid in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 15;879(26):2827-33.

Title: Schmidt-Hansen M, et al. Simultaneous compared to interval administration of mifepristone and misoprostol for medical abortion up to 10+0 weeks' gestation: a systematic review with meta-analyses. BMJ Sex Reprod Health. 2020 Feb 20. pii: bmjsrh-2019-200448.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:112137-89-0 Molecular Formula|112137-89-0 MDL|112137-89-0 SMILES|112137-89-0 (+/-)-15-DEOXY-[16RS]-16-HYDROXY-16-METHYLPROSTAGLANDIN E1
Catalog No.: AA008RHA
112137-89-0,MFCD00869984
112137-89-0 | (+/-)-15-DEOXY-[16RS]-16-HYDROXY-16-METHYLPROSTAGLANDIN E1
Pack Size: 1mg
Purity: ≥97%
in stock
$80.00 $56.00
Pack Size: 5mg
Purity: ≥97%
in stock
$356.00 $249.00
Pack Size: 10mg
Purity: ≥97%
in stock
$670.00 $469.00
Pack Size: 50mg
Purity: ≥97%
in stock
$2,358.00 $1,650.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008RHA
Chemical Name: (+/-)-15-DEOXY-[16RS]-16-HYDROXY-16-METHYLPROSTAGLANDIN E1
CAS Number: 112137-89-0
Molecular Formula: C21H36O5
Molecular Weight: 368.5075
MDL Number: MFCD00869984
SMILES: CCCCC(CC=CC1C(O)CC(=O)C1CCCCCCC(=O)O)(O)C
Properties
Complexity: 473  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 3  
Defined Bond Stereocenter Count: 1  
Formal Charge: 0  
Heavy Atom Count: 26  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 13  
Undefined Atom Stereocenter Count: 1  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.3  
Downstream Synthesis Route
4846-21-3    112137-89-0    2641624-12-4 

[1]CurrentPatentAssignee:YOOOOKJOON;LIFEXBIOLABS-US2021/139435,2021,A1Locationinpatent:Paragraph0171-0173

15457-50-8    112137-89-0    2641623-96-1 

[1]CurrentPatentAssignee:YOOOOKJOON;LIFEXBIOLABS-US2021/139435,2021,A1Locationinpatent:Paragraph0147-0149

Literature fold

Title: Validated method for the determination of misoprostol acid in whole blood by ultra performance liquid chromatography-tandem mass spectrometry.

Journal: Journal of pharmaceutical and biomedical analysis20121201

Title: Effect of bacterial vaginosis on the pharmacokinetics of misoprostol in early pregnancy.

Journal: Human reproduction (Oxford, England)20120201

Title: Development and validation of highly sensitive method for determination of misoprostol free acid in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20110915

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Pharmacokinetics of repeated doses of misoprostol.

Journal: Human reproduction (Oxford, England)20090801

Title: Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.

Journal: Human reproduction (Oxford, England)20070701

Title: Determination of misoprostol acid in human plasma by liquid chromatography coupled to tandem mass spectrometry.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20070601

Title: The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration.

Journal: European journal of obstetrics, gynecology, and reproductive biology20030501

Title: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

Journal: Biochimica et biophysica acta20000117

Title: Vijaya Bharathi D, et al. Development and validation of highly sensitive method for determination of misoprostol free acid in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 15;879(26):2827-33.

Title: Schmidt-Hansen M, et al. Simultaneous compared to interval administration of mifepristone and misoprostol for medical abortion up to 10+0 weeks' gestation: a systematic review with meta-analyses. BMJ Sex Reprod Health. 2020 Feb 20. pii: bmjsrh-2019-200448.

Building Blocks More >
103788-64-3
103788-64-3
METHYL 2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ACETATE
AA008RNW | MFCD00203858
110623-73-9
110623-73-9
Epimedin b
AA008RXX | MFCD04039834
1050505-83-3
1050505-83-3
4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine
AA008S4D | MFCD03412096
1075719-87-7
1075719-87-7
2-(4-ethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
AA008SDG | MFCD18643353
104145-95-1
104145-95-1
Cefditoren
AA008SKY | MFCD00865118
1124175-25-2
1124175-25-2
Methyl (1r,3r)-3-hydroxycyclopentanecarboxylate
AA008SQO | MFCD28962589
105078-92-0
105078-92-0
17ALPHA-HYDROXYPREGNENOLONE-21,21,21-D3
AA008SX0 | MFCD01317456
104579-03-5
104579-03-5
5'-O-(4,4'-Dimethoxytrityl)-N4-benzoyl-5-methyl-2'-deoxycytidine
AA008T57 | MFCD00057965
1206101-20-3
1206101-20-3
GLPG0634 analog
AA008TDP | MFCD26406012
1123231-07-1
1123231-07-1
WAY-262611
AA008THU | MFCD20527803
Submit
© 2017 AA BLOCKS, INC. All rights reserved.